Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes Lissdaniels

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Economics and Human Biology|November 30, 2025
Income-related mortality inequality and macroeconomic conditionsJohannes Lissdaniels, Ulf-G Gerdtham, Gawain Heckley
ESC Heart Failure|January 27, 2024
Estimating the clinical and budgetary impact of using angiotensin receptor neprilysin inhibitor as first line therapy in patients with HFrEFNicklas Bergh, Krister Lindmark, Johannes Lissdaniels, et al.
Journal of Health Economics|October 3, 2017
Mortality and the business cycle: Evidence from individual and aggregated dataGerard J van den Berg, Ulf-G Gerdtham, Stephanie von Hinke, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Economics and Human Biology|November 30, 2025
Income-related mortality inequality and macroeconomic conditionsJohannes Lissdaniels, Ulf-G Gerdtham, Gawain Heckley
ESC Heart Failure|January 27, 2024
Estimating the clinical and budgetary impact of using angiotensin receptor neprilysin inhibitor as first line therapy in patients with HFrEFNicklas Bergh, Krister Lindmark, Johannes Lissdaniels, et al.
Journal of Health Economics|October 3, 2017
Mortality and the business cycle: Evidence from individual and aggregated dataGerard J van den Berg, Ulf-G Gerdtham, Stephanie von Hinke, et al.
Pageof 1